CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors
2015 ◽
Vol 15
(8)
◽
pp. 988-1011
◽
2008 ◽
Vol 56
(3)
◽
pp. 97-103
◽
2009 ◽
Vol 19
(8)
◽
pp. 2333-2337
◽
2003 ◽
Vol 17
(8)
◽
pp. 475-493
◽